Literature DB >> 34616031

Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.

Masaaki Ito1,2, Ryuji Okamoto3,4, Hiromasa Ito3, Ye Zhe3, Kaoru Dohi3.   

Abstract

The regulation of muscle contraction is a critical function in the cardiovascular system, and abnormalities may be life-threatening or cause illness. The common basic mechanism in muscle contraction is the interaction between the protein filaments myosin and actin. Although this interaction is primarily regulated by intracellular Ca2+, the primary targets and intracellular signaling pathways differ in vascular smooth muscle and cardiac muscle. Phosphorylation of the myosin regulatory light chain (RLC) is a primary molecular switch for smooth muscle contraction. The equilibrium between phosphorylated and unphosphorylated RLC is dynamically achieved through two enzymes, myosin light chain kinase, a Ca2+-dependent enzyme, and myosin phosphatase, which modifies the Ca2+ sensitivity of contractions. In cardiac muscle, the primary target protein for Ca2+ is troponin C on thin filaments; however, RLC phosphorylation also plays a modulatory role in contraction. This review summarizes recent advances in our understanding of the regulation, physiological function, and pathophysiological involvement of RLC phosphorylation in smooth and cardiac muscles.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Myosin light chain kinase; Myosin light chain phosphorylation; Myosin phosphatase; Rho-kinase; RhoA

Mesh:

Substances:

Year:  2021        PMID: 34616031     DOI: 10.1038/s41440-021-00733-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  165 in total

1.  Definition of the inhibitory domain of smooth muscle myosin light chain kinase by site-directed mutagenesis.

Authors:  M Ito; V Guerriero; X M Chen; D J Hartshorne
Journal:  Biochemistry       Date:  1991-04-09       Impact factor: 3.162

Review 2.  Signaling to myosin regulatory light chain in sarcomeres.

Authors:  Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

Review 3.  Biochemistry of smooth muscle myosin light chain kinase.

Authors:  Feng Hong; Brian D Haldeman; Del Jackson; Mike Carter; Jonathan E Baker; Christine R Cremo
Journal:  Arch Biochem Biophys       Date:  2011-05-03       Impact factor: 4.013

Review 4.  Role of myosin light chain phosphatase in cardiac physiology and pathophysiology.

Authors:  Audrey N Chang; Kristine E Kamm; James T Stull
Journal:  J Mol Cell Cardiol       Date:  2016-10-11       Impact factor: 5.000

Review 5.  The significance of regulatory light chain phosphorylation in cardiac physiology.

Authors:  Sarah B Scruggs; R John Solaro
Journal:  Arch Biochem Biophys       Date:  2011-02-21       Impact factor: 4.013

Review 6.  Regulation of myosin light chain kinase and telokin expression in smooth muscle tissues.

Authors:  B Paul Herring; Omar El-Mounayri; Patricia J Gallagher; Feng Yin; Jiliang Zhou
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-14       Impact factor: 4.249

Review 7.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

Review 8.  Getting the skinny on thick filament regulation in cardiac muscle biology and disease.

Authors:  Farah Sheikh; Robert C Lyon; Ju Chen
Journal:  Trends Cardiovasc Med       Date:  2013-08-19       Impact factor: 6.677

Review 9.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 10.  Vascular smooth muscle contraction in hypertension.

Authors:  Rhian M Touyz; Rheure Alves-Lopes; Francisco J Rios; Livia L Camargo; Aikaterini Anagnostopoulou; Anders Arner; Augusto C Montezano
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

View more
  1 in total

1.  Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta.

Authors:  Yunting Jian; Lingzhi Kong; Hongyi Xu; Yawei Shi; Xinjian Huang; Wenjing Zhong; Shumei Huang; Yue Li; Dongni Shi; Yunyun Xiao; Muwen Yang; Siqi Li; Xiangfu Chen; Ying Ouyang; Yameng Hu; Xin Chen; Libing Song; Runyi Ye; Weidong Wei
Journal:  Clin Transl Med       Date:  2022-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.